Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCR-002 in Acute Liver Failure/Injury (STOP-ALF)
NCT01548690Phase 2Completed
- Start
- Jun 2012
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
A Phase 2 trial of ornithine phenylacetate in acute liver failure (ALF), acute liver injury (ALI). Started Jun 2012; status: completed.
02
Drugs
ornithine phenylacetate
03
Conditions
acute liver failure (ALF)acute liver injury (ALI)
Beyond the preview
Go deeper on NCT01548690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548690.